GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (NYSE:NVS) » Definitions » Price-to-Owner-Earnings

Novartis AG (Novartis AG) Price-to-Owner-Earnings

: 9.66 (As of Today)
View and export this data going back to 1996. Start your Free Trial

As of today (2024-04-19), Novartis AG's share price is $94.11. Novartis AG's Owner Earnings per Share (TTM) ended in Dec. 2023 was $9.74. It's Price-to-Owner-Earnings for today is 9.66.


The historical rank and industry rank for Novartis AG's Price-to-Owner-Earnings or its related term are showing as below:

NVS' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.21   Med: 13.04   Max: 33.81
Current: 9.67

During the past 13 years, the highest Price-to-Owner-Earnings of Novartis AG was 33.81. The lowest was 6.21. And the median was 13.04.


NVS's Price-to-Owner-Earnings is ranked better than
88.12% of 421 companies
in the Drug Manufacturers industry
Industry Median: 27.51 vs NVS: 9.67

As of today (2024-04-19), Novartis AG's share price is $94.11. Novartis AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $7.10. Therefore, Novartis AG's PE Ratio for today is 13.25.

As of today (2024-04-19), Novartis AG's share price is $94.11. Novartis AG's EPS without NRI for the trailing twelve months (TTM) ended in was $4.19. Therefore, Novartis AG's PE Ratio without NRI for today is 22.46.

During the past 13 years, Novartis AG's highest PE Ratio without NRI was 29.71. The lowest was 7.45. And the median was 22.00.


Novartis AG Price-to-Owner-Earnings Historical Data

The historical data trend for Novartis AG's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.81 14.27 6.45 15.03 9.54

Novartis AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.03 13.50 14.13 13.10 9.54

Competitive Comparison

For the Drug Manufacturers - General subindustry, Novartis AG's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis AG Price-to-Owner-Earnings Distribution

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Novartis AG's Price-to-Owner-Earnings falls into.



Novartis AG Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Novartis AG's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=94.11/9.74
=9.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis AG  (NYSE:NVS) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Novartis AG Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Novartis AG's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis AG (Novartis AG) Business Description

Address
Lichtstrasse 35, Basel, CHE, 4056
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Novartis AG (Novartis AG) Headlines